The National Medicines Safety Agency (ANSM) has just recalled a batch of cholesterol medications on November 21, due to a packaging error. A tablet of medication against type 2 diabetes was indeed discovered in a bottle of tablets against cholesterol. The medicine concerned is as follows: Atorvastatin Arrow Generics 10 mg, bottle of 30 film-coated tablets Lot JBM2300810F Exp: 07/2025 CIP code: 34009 300 353 2 0
A risk of hypoglycemia
“This recall is being carried out as a precautionary measure following the detection of a Gliclazide 30 mg modified release tablet in a bottle of Atorvastatin tablets from this batch. This packaging error has only been reported to date for one single bottle” underlines the ANSM in its press release. “The risk for patients who take gliclazide instead of atorvastatin is hypoglycemia” explain the health authorities. But the ANSM reassures: “no case of pharmacovigilance linked to the quality defect has been reported to the laboratory to date”. If you have one of these bottles at home (they have been on the market since March 2024), take it back to your pharmacist, who will exchange it. To find out if you have a bottle that comes from the lot, JBM2300810F, look at the reference written on it. If a reference other than JBM2300810F is entered, you are not affected by (…)
Read more on Top Santé
The No. 1 Sign Women Too Often Ignore Before a Heart Attack, Experts Say
How to use a blood glucose meter? A diabetologist gives you instructions for use
A professor of medicine strongly advises against storing these 4 foods in the refrigerator
Black Friday 2024: preserve all the flavors of your food with this ultra practical steam basket!
The Skarlett Assurances brokerage service
